ELMMB logo
Facebook logo Twitter logo
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 4th January 2022      MHRA Press Release Strong Steroid found in 'natural' skin cream. MHRA have issued a recall asking patients
                                     to return affected products.
11th Nov 2021           News Release Patient safety priority in recall of batches of cold and flu medicine with labelling error.
15th Sept 2021          MHRA Press Release The MHRA is advising anyone experiencing skin redness or burning sensations after
                                     they have stopped using these creams or ointments to seek advice from their health professional before
                                     using these products again.
 9th August 2021       MHRA Press Release MHRA recalls contaminated Irbesartan-batches as a precautionary measure. 
                                                                        Patients should not stop any treatments without consulting their doctor or pharmacist.
 8th July 2021             MHRA Press Release First progesterone-only contraceptive pills to be available to purchase from pharmacies      
 1st July 2021             Company led medicines recall: Morphine Syringe 50mg/50ml [unlicensed medicine] and Magnesium Sulphate
                                                                                         8mmol/20ml infusion [unlicensed medicine]
 17th June 2021         MHRA Press Release  MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
 8th June 2021           MHRA Press Release  Over 3 million medicines and devices seized in UK as part of global crackdown
 28th May 2021         MHRA Press Release A personal trainer sentenced to 31 months in jail for selling and supplying unlicensed and                                                                                prescription medicines, together with Anabolic steroids, to the public.        
 4th May 2021           MHRA Press Release  MHRA announces appointment of Chief Safety Officer

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

application/pdfValsartan Class 1 medicines recall EL_18_A_11-_revision_1.pdf (62KB)11/07/2018Download
 The Drug Alert EL (18)A/11 issued on 5 July 2018 is now superseded by this revised alert EL (18)A/11 – revision 1 because Actavis (now Accord) has provided new information that an additional product... 
application/pdfFiasp FlexTouch 100units per mL class 2 medicines recall 090718.pdf (31KB)09/07/2018Download
 Novo Nordisk is recalling one batch as a precautionary measure due to the presence of particles in a small number of samples. 
application/pdfValsartan Class 1 Medicines Recall ACTION NOW 050718 EL_18_A_11.pdf (62KB)06/07/2018Download
 Valsartan Class 1 Medicines Recall ACTION NOW Pharmacies in the UK are being advised to recall all batches of valsartan containing medicines made by Dexcel Pharma Ltd and Accord Healthcare... 
application/pdfInhixa sol for injection Class 4 medicines recall april 2018.pdf (263KB)27/04/2018Download
 Inhixa soln for injection. Class 4 medicines defect information april 2018 
application/pdfLynparza Class 3 MEDICINES RECALL 120318_astra zeneca.pdf (135KB)12/03/2018Download
 AstraZeneca is recalling batch NG327 as the level of olaparib polymorphic form L exceeds the registered specification limit. As a precautionary measure additional batches are also being recalled... 
application/pdfVentolin Accuhaler Class 2 Medicines recall 0218 EL_18_A03-Final.pdf (436KB)22/02/2018Download
 Glaxo Wellcome UK Limited is recalling Lots 786G and 754P of Ventolin Accuhaler 200mcg because a manufacturing issue with these Lots has been identified which has resulted in a small number of units... 
application/pdfSeretide Accuhaler Class 2 Medicines recall 0218_EL(18)A_04.pdf (290KB)22/02/2018Download
 Glaxo Wellcome UK Limited is recalling LOT 5K8W of Seretide Accuhaler 50/250mcg because a manufacturing issue with this Lot has been identified which has resulted in a small number of units not... 
application/pdfEsmya _ulipristal_ uterine fibroids -MHRA letter February 2018.pdf (62KB)15/02/2018Download
application/pdfMagnevist and Omniscan sol for inj_class 2 medicines recall MHRA.pdf (153KB)02/02/2018Download
 All unexpired stock of the above products marketed by Bayer plc and GE Healthcare AS is being recalled and should immediately be quarantined. This follows a safety review of the gadolinium EL (18)... 
application/pdfMolipaxin 100mg capsules Class 2 medicines recall.pdf (229KB)04/01/2018Download
 A precautionary recall is being carried out due to the potential that during manufacture of the batch, the metal detector may not have functioned and therefore that the presence of metal particles... 
application/pdfBuccolam (midazolam) oromucosal soln pf. - Class 4 medicines defect infformation.pdf (315KB)07/12/2017Download
 As outlined in the DHCP attached, we ask you share this information with your patients' parents and caregivers, and with age-appropriate patients, during your interactions with them going forward to... 
application/pdfLipitor (atorvastatin) 80mg fc tablets Class 2 medicines recall MHRA.pdf (133KB)27/11/2017Download
 Pfizer is recalling the above batches as a precaution due to an out of specification result for microbiological testing during routine stability studies on a batch of the product which was not... 
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]